Cellular Senescence in Lung Fibrosis
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Fibrosing interstitial lung diseases (ILDs) are chronic and ultimately fatal age-related lung diseases characterized by the progressive and irreversible accumulation of scar tissue in the lung parenchyma. Over the past years, significant progress has been made in our incomplete understanding of the pathobiology underlying fibrosing ILDs, in particular in relation to diverse age-related processes and cell perturbations that seem to lead to maladaptation to stress and susceptibility to lung fibrosis. Growing evidence suggests that a specific biological phenomenon known as cellular senescence plays an important role in the initiation and progression of pulmonary fibrosis. Cellular senescence is defined as a cell fate decision caused by the accumulation of unrepairable cellular damage and is characterized by an abundant pro-inflammatory and pro-fibrotic secretome. The senescence response has been widely recognized as a beneficial physiological mechanism during development and in tumour suppression. However, recent evidence strengthens the idea that it also drives degenerative processes such as lung fibrosis, most likely by promoting molecular and cellular changes in chronic fibrosing processes. Here, we review how cellular senescence may contribute to lung fibrosis pathobiology, and we highlight current and emerging therapeutic approaches to treat fibrosing ILDs by targeting cellular senescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 2×
“Evolutionary theories of the pathogenesis of lung fibrosis propose all the “hallmarks of aging” as major mechanisms of disease, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaus…”
BackgroundSelf-citationOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“The irreversibility was considered a key factor for discerning cellular senescence from quiescence and transient cell cycle arrest, bringing senescence into the spotlight as a cancer-suppressor and a possible contributor to aging [9,12,13].”
BackgroundSelf-citationEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103 · cited 1×
“IPF is a progressive, irreversible and fatal lung disease characterized by scarring and thickening of the interstitial lung tissue leading to cough, dyspnoea and, ultimately, respiratory failure and death [2,25].”
BackgroundA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 1×
“As a response to lung injury, many interrelated woundhealing pathways are activated in order to facilitate the repair, turnover, and adaptation of lung tissue [7].”
BackgroundAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“It has been shown that aged and diseased tissues of multiple multicellular organisms are more abundant in senescent cells [10,31,32].”
BackgroundInfluentialNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 5×
“Dasatinib, which has been approved for clinical use in the United States since 2006 for the treatment of chronic myelogenous leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia, also impairs the viability of senescent preadipocytes by reducing the expression of p21, PAI-1 and BCL-xL [91].”
BackgroundInfluentialSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Lederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056
Understanding the odd science of aging
Kirkwood, T. B. L. (2005) · Cell · doi:10.1016/j.cell.2005.01.027 · Cited by 1,984 · cited 1×
“The lack of somatic maintenance and repair functions and the stochastic enforcement of damage may explain the marked variability of cellular mechanisms that appear to be involved in aging phenotypes, such as lung fibrosis [3,4].”
BackgroundClearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 2×
“Navitoclax (ABT-263, a specific inhibitor of the antiapoptotic proteins BCL-2 and BCL-xL), effectively cleared senescent cells in young p163MR exposed to sublethal doses of radiation that induced a significant increase in senescent cells [72].”
BackgroundKirkwood, T. B. L., & Austad, S. N. (2000) · Nature · doi:10.1038/35041682 · Cited by 1,774
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 3×
“However, when the combined treatment was tested in mice with established lung fibrosis after 2–4 weeks of bleomycin administration, the expression of inflammatory markers was diminished, but attenuation of lung fibrosis failed [69].”
BackgroundBaar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284 · cited 1×
“Evidence provides support to the idea that senescent cells can fuel the hallmarks of a variety of aging phenotypes and overt age-related diseases, largely through the cell paracrine effects of the SASP [33].”
BackgroundMitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275 · cited 1×
“Moreover, growing body of evidence suggests that aging induces mitochondrial impairment in different cells associating metabolic changes, and has been shown to induce cellular senescence, a process called mitochondrial dysfunction-associated senescence [45].”
BackgroundSenolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261 · cited 1×
“Dasatinib plus Quercetin (3 days/week over 3 weeks) in stable IPF patients (N = 14) [93].”
BackgroundReyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
Molecular inflammation: Underpinnings of aging and age-related diseases
Chung, H. Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A. Y., Carter, C., Yu, B. P., & Leeuwenburgh, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.002 · Cited by 1,203
Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160
Zhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 2×
“In addition, targeting BCL-2 family proteins is senolytic in a limited number of cell types, suggesting that testing the restricted effect on every cell type of interest should be considered during the senolytic drug development process [29,97].”
BackgroundOxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116
Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
Feedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019 · cited 1×
“It also has been shown that in normally proliferating cells, such as human fibroblasts, there is a dynamic feedback loop in which the long-term activation of the checkpoint gene CDKN1A (p21) induces mitochondrial dysfunction and reactive oxygen species (ROS) production, which is considered necessary for the establishm…”
BackgroundAdult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
Wilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876 · cited 1×
“Another candidate, Navitoclax (ABT-263), which is a specific inhibitor of the antiapoptotic proteins BCL-2 and BCL-xL, was identified from an agent library as having substantial off-target apoptotic effects on non-senescent cell types such as platelets and immune cells, making them potentially ‘panolytic’, causing apo…”
BackgroundMild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?
von Zglinicki, T., Saretzki, G., Döcke, W., & Lotze, C. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1305 · Cited by 856
Zhu, Y., Doornebal, E. J., Pirtskhalava, T., Giorgadze, N., Wentworth, M., Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., Robbins, P. D., Tchkonia, T., & Kirkland, J. L. (2017) · Aging · doi:10.18632/aging.101202 · Cited by 757
Spectrum of fibrotic lung diseases
Wijsenbeek, M., & Cottin, V. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2005230 · Cited by 736
Identification of HSP90 inhibitors as a novel class of senolytics
Fuhrmann-Stroissnigg, H., Ling, Y. Y., Zhao, J., McGowan, S. J., Zhu, Y., Brooks, R. W., Grassi, D., Gregg, S. Q., Stripay, J. L., Dorronsoro, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00314-z · Cited by 701
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686 · cited 3×
“A preclinical in vivo study in aging mice with genetic and pharmacological targeting of NOX4 treated with bleomycin showed a significant decrease in senescent fibroblast and collagen deposition, and also reversed established lung fibrosis [8].”
BackgroundInfluentialMoiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74942 · Cited by 627 · cited 1×
“elegantly showed that some potential mechanisms involve in inducement of ER stress, such as herpes virus infection or exposure to cigarette smoke, influencing susceptibility to agerelated lung diseases [61,62].”
BackgroundSelf-citationTelomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-550oc · Cited by 573
Cancer and ageing: rival demons?
Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512
Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence
Jiang, P., Du, W., Mancuso, A., Wellen, K. E., & Yang, X. (2013) · Nature · doi:10.1038/nature11776 · Cited by 491
Cellular senescence: a link between cancer and age-related degenerative disease?
Campisi, J., Andersen, J. K., Kapahi, P., & Melov, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.001 · Cited by 421 · cited 1×
“It has been shown that aged and diseased tissues of multiple multicellular organisms are more abundant in senescent cells [10,31,32].”
BackgroundDanazol Treatment for Telomere Diseases
Townsley, D. M., Dumitriu, B., Liu, D., Biancotto, A., Weinstein, B., Chen, C., Hardy, N., Mihalek, A. D., Lingala, S., Kim, Y. J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515319 · Cited by 415
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403 · cited 1×
“Based on their known targets, a combination therapy with Dasatinib and Quercetin not only was proved to clear senescent cells in vivo in chronologically aged progeroid mice, decreasing irradiation-induced cardiac dysfunction, but also impaired senescence and SASP markers (IL-6, IL8, MCP-1, PAI-1 and GM-CSF) in isolate…”
BackgroundRapamycin decelerates cellular senescence
Demidenko, Z. N., Zubova, S. G., Bukreeva, E. I., Pospelov, V. A., Pospelova, T. V., & Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8606 · Cited by 391
Identification and characterization of Cardiac Glycosides as senolytic compounds
Triana-Martínez, F., Picallos-Rabina, P., Da Silva-Álvarez, S., Pietrocola, F., Llanos, S., Rodilla, V., Soprano, E., Pedrosa, P., Ferreirós, A., Barradas, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12888-x · Cited by 384
Self-citationTelomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010680 · Cited by 377
Cellular senescence: putting the paradoxes in perspective
Campisi, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.005 · Cited by 368
IPF lung fibroblasts have a senescent phenotype
Álvarez, D., Cárdenes, N., Sellarés, J., Bueno, M., Corey, C., Hanumanthu, V. S., Peng, Y., D’Cunha, H., Sembrat, J., Nouraie, M., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00220.2017 · Cited by 342 · cited 2×
“Cellular senescence of AEC2s and lung fibroblasts of patients with IPF determine a cellular phenotype with the hyperactive secretion of a set of pro-fibrotic SASP’s cytokines, growth factors, angiostatic and procoagulant mediators, and proteases that promote an abnormal wound healing response [20,49,50].”
BackgroundSelf-citationWatanabe, S., Kawamoto, S., Ohtani, N., & Hara, E. (2017) · Cancer Science · doi:10.1111/cas.13184 · Cited by 321 · cited 2×
“Alterations in the secretome of senescent cells with a chronic increment of production of several inflammatory secretory proteins, including plasminogen activator inhibitor-1 (PAI-1), matrix remodelling proteins (MMPs), growth factors such as TGFβ1, as well as other initial inflammatory stimuli, including IL-6, IL-8 a…”
BackgroundLiang, J., Zhang, Y., Xie, T., Liu, N., Chen, H., Geng, Y., Kurkciyan, A., Mena, J. M., Stripp, B. R., Jiang, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4192 · Cited by 287 · cited 1×
“Another consequence of cellular senescence is the exhaustion of AEC2, the alveolar stem cells, leading to reductions in the regenerative capacity of these cells in the context of fibrogenic injury [83].”
BackgroundAbnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
Faner, R., Rojas, M., MacNee, W., & Agustí, A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0282pp · Cited by 268 · cited 1×
“The pathogenesis of fibrotic lung tissue remodelling is a dynamic orchestrated process and is thought to be strongly linked to aging [4,22].”
BackgroundSelf-citationTelomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Naikawadi, R. P., Disayabutr, S., Mallavia, B., Donne, M. L., Green, G., La, J. L., Rock, J. R., Looney, M. R., & Wolters, P. J. (2016) · JCI Insight · doi:10.1172/jci.insight.86704 · Cited by 267
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3765 · Cited by 246 · cited 1×
“Navitoclax acts as a selective, secure, and useful anti-fibrotic agent for reversing organ fibrosis in vivo [112,113].”
BackgroundMice with Pulmonary Fibrosis Driven by Telomere Dysfunction
Povedano, J. M., Martinez, P., Flores, J. M., Mulero, F., & Blasco, M. A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.028 · Cited by 225 · cited 1×
“Animal models with telomere deficiency in telomerase reverse transcriptase (TERT) have been shown to develop lung fibrosis with higher frequency after repeated low doses of bleomycin [44].”
BackgroundBleomycin induces cellular senescence in alveolar epithelial cells
Aoshiba, K., Tsuji, T., & Nagai, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00011903 · Cited by 197 · cited 1×
“Under normal conditions, AEC2s can self-renew and differentiate into type I alveolar epithelial cells and therefore are considered as alveolar progenitor cells [47,48].”
BackgroundMetformin‐mediated increase in DICER1 regulates microRNA expression and cellular senescence
Noren Hooten, N., Martin‐Montalvo, A., Dluzen, D. F., Zhang, Y., Bernier, M., Zonderman, A. B., Becker, K. G., Gorospe, M., Cabo, R., & Evans, M. K. (2016) · Aging Cell · doi:10.1111/acel.12469 · Cited by 196
The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging
McQuattie-Pimentel, A. C., Ren, Z., Joshi, N., Watanabe, S., Stoeger, T., Chi, M., Lu, Z., Sichizya, L., Aillon, R. P., Chen, C.-I., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140299 · Cited by 177
Discovery, development, and future application of senolytics: theories and predictions
Wissler Gerdes, E. O., Zhu, Y., Tchkonia, T., & Kirkland, J. L. (2020) · The FEBS Journal · doi:10.1111/febs.15264 · Cited by 160 · cited 1×
“Currently, senotherapy includes several senolytic agents found to be targeting diverse network nodes that have been identified as critical for protecting senescent cells from apoptosis (Table 1) [89,90].”
BackgroundOzsvari, B., Nuttall, J. R., Sotgia, F., & Lisanti, M. P. (2018) · Aging · doi:10.18632/aging.101633 · Cited by 138
Disayabutr, S., Kim, E. K., Cha, S.-I., Green, G., Naikawadi, R. P., Jones, K. D., Golden, J. A., Schroeder, A., Matthay, M. A., Kukreja, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158367 · Cited by 136 · cited 1×
“Moreover, a PAI1 inhibitor (TM5275) blocked fibrosis in mice with bleomycin-induced lung fibrosis and protected AEC2s from senescence by targeting the p53 pathway [109].”
BackgroundSenotherapeutics: targeting senescence in idiopathic pulmonary fibrosis
Merkt, W., Bueno, M., Mora, A. L., & Lagares, D. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.008 · Cited by 119 · cited 1×
“While p21 expression is driven by telomere shortening-induced p53 activity, p16Ink4a is upregulated by telomereindependent unknown mechanisms [70].”
BackgroundSenescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury
Aoshiba, K., Tsuji, T., Kameyama, S., Itoh, M., Semba, S., Yamaguchi, K., & Nakamura, H. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.04.001 · Cited by 100 · cited 1×
“Under normal conditions, AEC2s can self-renew and differentiate into type I alveolar epithelial cells and therefore are considered as alveolar progenitor cells [47,48].”
BackgroundP53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis
Mahfoudhi, E., Lordier, L., Marty, C., Pan, J., Roy, A., Roy, L., Rameau, P., Abbes, S., Debili, N., Raslova, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7881 · Cited by 53 · cited 1×
“Another candidate, Navitoclax (ABT-263), which is a specific inhibitor of the antiapoptotic proteins BCL-2 and BCL-xL, was identified from an agent library as having substantial off-target apoptotic effects on non-senescent cell types such as platelets and immune cells, making them potentially ‘panolytic’, causing apo…”
Background
Research works printed but not linked: 50
- Wynn, 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases, J. Clin. Investig., 117, 524, 10.1172/JCI31487 · DOI · Paper page
- Travis, 2013, An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am. J. Respir. Crit. Care Med., 188, 733, 10.1164/rccm.201308-1483ST · DOI · Paper page
- Kapetanaki, 2013, Influence of age on wound healing and fibrosis, J. Pathol., 229, 310, 10.1002/path.4122 · DOI · Paper page
- Wynn, 2011, Integrating mechanisms of pulmonary fibrosis, J. Exp. Med., 208, 1339, 10.1084/jem.20110551 · DOI · Paper page
- Barkauskas, 2014, Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis, Am. J. Physiol. Cell Physiol., 306, C987, 10.1152/ajpcell.00321.2013 · DOI · Paper page
- Hayflick, 1965, The Limited in Vitro Lifetime of Human Diploid Cell Strains, Exp. Cell Res., 37, 614, 10.1016/0014-4827(65)90211-9 · DOI · Paper page
- Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- Hornsby, 2002, Cellular senescence and tissue aging in vivo, J. Gerontol. A Biol. Sci. Med. Sci., 57, B251, 10.1093/gerona/57.7.B251 · DOI · Paper page
- Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 · DOI · Paper page
- Hamsanathan, 2019, Cellular Senescence: The Trojan Horse in Chronic Lung Diseases, Am. J. Respir. Cell Mol. Biol., 61, 21, 10.1165/rcmb.2018-0410TR · DOI · Paper page
- Selman, 2014, Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model, Am. J. Respir. Crit. Care Med., 189, 1161, 10.1164/rccm.201312-2221PP · DOI · Paper page
- Pardo, 2016, Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis, Ann. Am. Thorac. Soc., 13, S417, 10.1513/AnnalsATS.201605-341AW · DOI · Paper page
- Schneider, 2021, The aging lung: Physiology, disease, and immunity, Cell, 184, 1990, 10.1016/j.cell.2021.03.005 · DOI · Paper page
- Mora, 2017, Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease, Nat. Rev. Drug Discov., 16, 755, 10.1038/nrd.2017.170 · DOI · Paper page
- Kropski, 2014, A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia, Chest, 146, e1, 10.1378/chest.13-2224 · DOI
- Borie, 2009, Prevalence of telomere shortening in familial and sporadic pulmonary fibrosis is increased in men, Am. J. Respir. Crit. Care Med., 179, 1073, 10.1164/ajrccm.179.11.1073 · DOI
- Borie, 2018, Clinical implications of telomere dysfunction in lung fibrosis, Curr. Opin. Pulm Med., 24, 440, 10.1097/MCP.0000000000000506 · DOI
- Lopez, 2019, Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis, Respirology, 24, 146, 10.1111/resp.13423 · DOI
- Wiley, 2019, Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis, JCI Insight, 4, e130056, 10.1172/jci.insight.130056 · DOI · Paper page
- Chondrogianni, 2015, Proteasome activation: An innovative promising approach for delaying aging and retarding age-related diseases, Ageing Res. Rev., 23, 37, 10.1016/j.arr.2014.12.003 · DOI
- Kropski, 2015, Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease, Am. J. Respir. Crit. Care Med., 191, 417, 10.1164/rccm.201406-1162OC · DOI · Paper page
- Tanjore, 2013, Endoplasmic reticulum stress as a pro-fibrotic stimulus, Biochim. Biophys. Acta, 1832, 940, 10.1016/j.bbadis.2012.11.011 · DOI · Paper page
- Baker, 2014, Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases, Physiol. Res., 63, 311, 10.33549/physiolres.932607 · doi:10.33549/physiolres.932607
- Semren, 2015, Regulation of 26S Proteasome Activity in Pulmonary Fibrosis, Am. J. Respir. Crit. Care Med., 192, 1089, 10.1164/rccm.201412-2270OC · DOI
- Jorgensen, E., Stinson, A., Shan, L., Yang, J., Gietl, D., and Albino, A.P. (2008). Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer, 8. · DOI · Paper page
- Lawson, 2008, Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: Association with altered surfactant protein processing and herpesvirus infection, Am. J. Physiol Lung Cell Mol. Physiol, 294, L1119, 10.1152/ajplung.00382.2007 · DOI · Paper page
- Bueno, 2012, Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis, Am. J. Respir. Cell Mol. Biol., 46, 748, 10.1165/rcmb.2011-0224OC · DOI · Paper page
- Beller, 2004, Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis, Proc. Natl. Acad. Sci. USA, 101, 3047, 10.1073/pnas.0400235101 · DOI
- Phan, 1987, Leukotriene C4 binds to rat lung fibroblasts and stimulates collagen synthesis, Adv. Prostaglandin Thromboxane Leukot Res., 17B, 997
- Smirnova, 2016, Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs, Respir. Res., 17, 83, 10.1186/s12931-016-0404-x · DOI · Paper page
- Xu, 2016, Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis, JCI Insight, 1, e90558, 10.1172/jci.insight.90558 · DOI · Paper page
- Mora, 2017, Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis, J. Clin. Investig., 127, 405, 10.1172/JCI87440 · DOI · Paper page
- Cheng, P., Li, S., and Chen, H. (2021). Macrophages in Lung Injury, Repair, and Fibrosis. Cells, 10. · DOI · Paper page
- Takenouchi, 2020, Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts, Exp. Cell Res., 391, 112010, 10.1016/j.yexcr.2020.112010 · DOI
- Chung, 2021, IGF-1 Receptor Signaling Regulates Type II Pneumocyte Senescence and Resulting Macrophage Polarization in Lung Fibrosis, Int. J. Radiat. Oncol. Biol. Phys., 110, 526, 10.1016/j.ijrobp.2020.12.035 · DOI
- Rana, 2020, PAI-1 Regulation of TGF-beta1-induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages, Am. J. Respir. Cell. Mol. Biol., 62, 319, 10.1165/rcmb.2019-0071OC · DOI · Paper page
- Popescu, 2019, Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres, Am. J. Respir. Crit. Care Med., 199, 362, 10.1164/rccm.201805-0825OC · DOI
- Cardenes, 2018, Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis, Stem Cell Res. Ther., 9, 257, 10.1186/s13287-018-0970-6 · DOI · Paper page
- Liu, 2020, Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy, Curr. Mol. Biol Rep., 6, 173, 10.1007/s40610-020-00141-0 · DOI · Paper page
- Antoniou, 2021, Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care, Curr. Opin. Pharmacol., 57, 71, 10.1016/j.coph.2020.12.007 · DOI
- Martel, 2020, Emerging use of senolytics and senomorphics against aging and chronic diseases, Med. Res. Rev., 40, 2114, 10.1002/med.21702 · DOI · Paper page
- Eid, 2010, AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes, J. Biol. Chem., 285, 37503, 10.1074/jbc.M110.136796 · DOI · Paper page
- Feng, 2006, Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence, Cell Cycle, 5, 2812, 10.4161/cc.5.23.3526 · DOI · Paper page
- Summer, 2019, Activation of the mTORC1/PGC-1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium, Am. J. Physiol. Lung Cell Mol. Physiol., 316, L1049, 10.1152/ajplung.00244.2018 · DOI · Paper page
- Zhang, X., Dong, Y., Li, W.C., Tang, B.X., Li, J., and Zang, Y. (2021). Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells. Acta Pharmacol. Sin. · DOI
- Kuehl, 2018, BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts, Matrix Biol., 68, 94, 10.1016/j.matbio.2018.01.020 · DOI · Paper page
- Pan, 2017, Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice, Int J. Radiat. Oncol. Biol. Phys., 99, 353, 10.1016/j.ijrobp.2017.02.216 · DOI · Paper page
- Kaefer, 2014, Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia, Cancer Chemother. Pharmacol., 74, 593, 10.1007/s00280-014-2530-9 · DOI · Paper page
- Plate, 2020, The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis, Eur. Respir. Rev., 29, 200269, 10.1183/16000617.0269-2020 · DOI
- Jarman, 2014, An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model, Am. J. Respir. Cell Mol. Biol., 50, 158, 10.1165/rcmb.2013-0174OC · DOI · Paper page
Cited by
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Alum, E., Izah, S., Uti, D., Ugwu, O., Betiang, P., Basajja, M., & Ejemot-Nwadiaro, R. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s543211 · Cited by 63
Advancing biological understanding of cellular senescence with computational multiomics
Li, S., Agudelo Garcia, P. A., Aliferis, C., Becich, M. J., Calyeca, J., Cosgrove, B. D., Elisseeff, J., Farzad, N., Fertig, E. J., Glass, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02314-y · Cited by 40
Self-citationZeyada, M. S., Eraky, S. M., & El-Shishtawy, M. M. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122272 · Cited by 31
Zhong, W., Chen, W., Liu, Y., Zhang, J., Lu, Y., Wan, X., Qiao, Y., Huang, H., Zeng, Z., Li, W., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200406rr · Cited by 23
Metadata
- Authors
- Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 7012
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3176748518
- Cited by
- 76
- References
- 67
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Instituto de Salud Carlos III (SLT008/18/00176)
- Federación Española de Enfermedades Raras (PI17/00369, 452 PI18/1008, PI19/01152)
- Miguel Servet Research contract (CP16/00039)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.